CASP3 and rhabdomyosarcoma: It showed that baicalin (50 μg/mL) decreased the expression of the FasL protein, a member of the tumor necrosis factor (TNF) family, and caspase-3, a marker of apoptosis, in an in vitro model of the infection in human embryonic rhabdomyosarcoma (RD) cells [19].